Haemonetics Corp (HAE)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$82.07

Buy

$84.50

arrow-down$-0.96 (-1.14%)

Prices updated at 12 Dec 2025, 21:18 EST

Prices minimum 15 mins delay

Prices in USD

Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Ms. Ellen M. Zane

CEO

Mr. Christopher A. Simon

Most recent earnings

31 Mar 2025

Fiscal year end

31 Mar 2025

Employees

3,023

Head office

125 Summer Street

Boston

United States

02110

+1 781 848-7100

olga.guyette@haemonetics.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Charles J. Dockendorff Independent Director	0.10m
Ms. Ellen M. Zane Chairman of the Board	0.25m
Mr. Michael J. Coyle Independent Director	0.08m
Dr. Mark W. Kroll,PhD,F.A.C.C.,F.H.R.S. Independent Director	0.08m
Mr. Robert E. Abernathy Independent Director	0.10m
Ms. Diane M. Bryant Independent Director	0.08m
Dr. Claire Pomeroy, M.B.A.,M.D. Independent Director	0.09m
Mr. Christopher A. Simon Director, President and Chief Executive Officer	1.10m
Ms. Michelle L. Basil Executive Vice President and General Counsel	0.54m
Mr. Lloyd E. Johnson Independent Director	0.08m
Ms. Laurie A. Miller Senior Vice President and Chief Human Resources Officer	-
Mr. James C. D’Arecca Executive Vice President and Chief Financial Officer	0.58m
Mr. Roy Galvin Executive Vice President and Chief Commercial Officer	0.49m
Ms. Maryanne Maunsell Farris Vice President and Chief Accounting Officer	-
Mr. Frank W. Chan Executive Vice President and Chief Operating Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	6,020,678
Vanguard Group Inc	4,953,332
Wellington Management Group, LLP	4,230,850
Neuberger Berman Investment Advisers LLC	3,670,282
Neuberger Berman Group LLC	3,670,282

Director dealings

Date chevron-l-regular chevron-r-regular	Action
01 Nov 2024	-
17 Sep 2024	-
29 Aug 2024	-
26 Jul 2024	-
25 Jul 2024	-
25 Jul 2024	-
25 Jul 2024	-
25 Jul 2024	-
25 Jul 2024	-
25 Jul 2024	-
25 Jul 2024	-
25 Jul 2024	-
24 Jul 2024	-
25 Jul 2024	-
12 Jul 2024	-
11 Jul 2024	-
06 Jun 2024	-
06 Jun 2024	-
06 Jun 2024	-
28 May 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.